1182.12.22 Boehringer Ingelheim Investigational Site

New York, New York

0 studies enrolling now · 1 studies all time

What they study most

HIV Infections

Studies at this site

• Randomized Evaluation of Strategic Intervention in Multidrug Resistant Patients With Tipranavir (RESIST) — Completed